| 000 | 01852 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517085549.0 | ||
| 264 | 0 | _c20170531 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1523-6838 | ||
| 024 | 7 |
_a10.1053/j.ajkd.2015.12.034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFakhouri, Fadi | |
| 245 | 0 | 0 |
_aTerminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cJul 2016 |
||
| 300 |
_a84-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAtypical Hemolytic Uremic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHourmant, Maryvonne | |
| 700 | 1 | _aCampistol, Josep M | |
| 700 | 1 | _aCataland, Spero R | |
| 700 | 1 | _aEspinosa, Mario | |
| 700 | 1 | _aGaber, A Osama | |
| 700 | 1 | _aMenne, Jan | |
| 700 | 1 | _aMinetti, Enrico E | |
| 700 | 1 | _aProvôt, François | |
| 700 | 1 | _aRondeau, Eric | |
| 700 | 1 | _aRuggenenti, Piero | |
| 700 | 1 | _aWeekers, Laurent E | |
| 700 | 1 | _aOgawa, Masayo | |
| 700 | 1 | _aBedrosian, Camille L | |
| 700 | 1 | _aLegendre, Christophe M | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 68 _gno. 1 _gp. 84-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ajkd.2015.12.034 _zAvailable from publisher's website |
| 999 |
_c25862055 _d25862055 |
||